A phase 3b, interventional, adaptive, clinical trial to evaluate the efficacy and safety of tralokinumab 300 mg every second week monotherapy compared with placebo in subjects with moderate-to-severe atopic hand eczema who are candidates for systemic therapy
Over the past years, biomolecular therapies including monoclonal antibodies, 5 , 6 , 7 , 8 , 9 , 10 plateletrich plasma (PRP) 11 , 12 , 13 or multipotent mesenchymal stromal cells (MSCs) 14 have been investigated to improve current pain treatment
OrangeTwist Hydrafacial Pricing starts from xxx
Promotes skin cell renewal and repairs damage from external factors, reduces dark spots, and gives the skin a smooth and even texture
Around 5% of afflicted patients are hospitalized in intensive care units (ICU) (5%) and around half of the hospitalized patients in ICU need oxygen therapy [,]